A mutation in a thioredoxin reductase homolog suppresses p53-induced growth inhibition in the fission yeast Schizosaccharomyces pombe

Molecular and General Genetics

Volumn 252, Issue 5, 1996, Pages 518-529

  Casso, David ^a,b,c   Beach, David ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

p53; Redox state; Schizosaccharomyces pombe; Thioredoxin reductase; Transcriptional reporter

Indexed keywords

OXIDIZING AGENT; PROTEIN P53; THIOREDOXIN REDUCTASE; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; FUNGUS GROWTH; FUNGUS MUTANT; GENE MUTATION; GROWTH INHIBITION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; SCHIZOSACCHAROMYCES POMBE; TUMOR SUPPRESSOR GENE;

CELL DIVISION; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, FUNGAL; GENES, P53; GENES, SUPPRESSOR; HUMANS; HYDROGEN PEROXIDE; MOLECULAR SEQUENCE DATA; MUTATION; OXYGEN; RECOMBINANT PROTEINS; SCHIZOSACCHAROMYCES; SEQUENCE HOMOLOGY, AMINO ACID; THIOREDOXIN REDUCTASE (NADPH); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

FUNGI; SCHIZOSACCHAROMYCES POMBE;

EID: 0029994196     PISSN: 00268925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004380050259     Document Type: Article

References (71)

1. Altschul SF, Gish W, Miller W, Meyers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403-410
2. Barak Y, Juven T, Haffner R, Oren M (1993) mdm-2 expression is induced by wild-type p53 activity. EMBO J 12:461-468
3. Bargonetti J, Manfredi JJ, Chen X, Marshak DR, Prives C (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev 7:2565-2574
4. + controls the transition from mitotic division to meiosis in fission yeast. Curr Genet 10:297-311
5. Bischoff JR, Casso D, Beach D (1991) A yeast system to study human p53. In: Origins of human cancer: a comprehensive review. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp 51-63
6. Bischoff JR, Casso D, Beach D (1992) Human p53 inhibits growth in the fission yeast Schizosaccharomyces pombe. Mol Cell Biol 12:1405-1411
7. + protein kinase. EMBO J 6: 3441-3447
8. Booher RN, Alpha CE, Hyams JS, Beach DH (1989) The fission yeast cdc2/cdc13/sucl protein kinase: regulation of catalytic activity and nuclear localization. Cell 58:485-497
9. Caelles C, Helmberg A, Karin M (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53 target genes. Nature 370:220-223
10. Chae HZ, Chung SJ, Rhee SG (1994a) Thioredoxin-dependent peroxide reductase from yeast. J Biol Chem 269:27670-27678
11. Chae HZ, Robison K, Poole LB, Church G, Storz G, Rhee SG (1994b) Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Nat Acad Sci USA 91:7017-7021
12. Cho YJ, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355
13. Cottarel G, Beach D, Deuschle LJ (1993) Two multipurpose multicopy Schizosaccharomyces pombe vectors pSP1 and pSP2. Curr Genet 23:547-548
14. Delphin C, Cahen P, Lawrence JJ, Baudier J (1994) Characterization of baculovirus recombinant wild-type p53. Dimerization of p53 is required for high affinity DNA binding and cysteine oxidation inhibits DNA binding. Eur J Biochem 223:683-692
15. Demple B (1991) Regulation of bacterial oxidative stress genes. Annu Rev Genet 25:315-337
16. Derman AI, Prinz WA, Belin D, Beckwith J (1993) Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science 262:1744-1747
17. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Defining of a consensus binding site for p53. Nature Genet 1:45-49
18. El-Deiry WS, Tokino T, Velculescu V, Levy D, Vogelstein B (1993) Waf-1: a potential mediator of p53 tumor suppression. Cell 75:817-825
19. Field J, Nikawa JI, Broek D, MacDonald B, Rodgers L, Wilson IA, Lerner RA, Wigler M (1988) Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Mol Cell Biol 8:2159-2165
20. Fields S, Jang SK (1990) Presence of a potent transcriptional activating sequence in the p53 protein. Science 249:1046-1049
21. Fornace AJ, Alamo IJ, Hollander MC (1988) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85:8800-8804
22. Forsburg SL, Guarente L (1988) Mutational analysis of upstream activation sequence 2 of the CYC1 gene of Saccharomyces cerevisiae: a HAP2-HAP3-responsive site. Mol Cell Biol 8: 647-654
23. Friend S (1994) p53: a glimpse at the puppet behind the shadow play. Science 265:334-335
24. Gannon JV, Lane DP (1991) Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349:802-805
25. Ginsberg D, Mechta F, Yaniv M, Oren M (1991) Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 88:9979-9983
26. Gutz H, Heslot H, Leupold U, Loprieno N (1974) Schizosaccharomyces pombe. In: King RC (ed) Handbook of genetics, vol. 1. Plenum Publishing, New York, pp 395-446
27. Haffner R, Oren M (1995) Biochemical properties and biological effects of p53. Curr Biol 5:84-90
28. Hainault P, Milner J (1993a) Redox modulation of p53 conformation and sequence-specific DNA binding. Cancer Res 53: 4469-4473
29. Hainault P, Milner J (1993b) A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Res 53:1739-1742
30. Hannon GJ, Casso D, Beach D (1994) KAP: a dual-specificity phosphatase that interacts with cyclin-dependent kinases. Proc Natl Acad Sci USA 91:1731-1735
31. Harlow E, Crawford LV, Pim PC, Williamson NM (1981) Monoclonal antibodies specific for simian virus 40 tumor antigen. J Virol 39:861-869
32. 1 cyclin dependent kinases. Cell 75:805-816
33. Holmgren A (1989) Thioredoxin and glutaredoxin systems. J Biol Chem 264:13693-13766
34. Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S (1994) Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 91:6098-6102
35. Jayaraman L, Prives C (1995) Activation of p53 sequence-specific binding by short single stands of DNA requires the p53 C-terminus. Cell 81:1021-1031
36. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BV, Vogelstein, Fornace AJ (1992) A mammalian cell cycle check point pathway utilizing p53 and GADD45 is defective in ataxia-telangectasia. Cell 71:587-597
37. Lane DP (1994) p53 and human cancers. Brit Med Bull 50:582-599
38. Leupold U (1970) Genetic methods for Schizosaccharomyces pombe. Methods Cell Physiol 4:169-177
39. Lee S, Elenbaas B, Levine A, Griffith J (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013-1020
40. +. Nature 355:449-453
41. Maltzman W, Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4:1689-1694
42. Martin DW, Munoz RM, Subler MA, Deb S (1993) p53 binds the TATA-binding protein-TATA complex. J Biol Chem 268:13062-13067
43. Martinez J, Georgoff I, Martinez J, Levine AJ (1991) Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151-159
44. Maundrell K (1993) Thiamine-repressible vectors pREP and pRIP for fission yeast. Gene 123:127-130
45. Maundrell K (1990) nmt1 of fission yeast: a highly transcribed gene completely repressed by thiamine. J Biol Chem 265:10857-10864
46. Mitomo K, Nakayama K, Fujimoto K, Sun X, Seki S, Yamamoto K (1994) Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145:197-203
47. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
48. Mizukami T, Chang WI, Garkavtsev I, Kaplan N, Lombardi D, Matsumoto T, Niwa O, Kounosu A, Yanagiga M, Marr TG, Beach D (1993) A 13 kb resolution cosmid map of the 14 Mb fission yeast genome by nonrandom sequence-tagged site mapping. Cell 73:121-132
49. Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262-7266
50. Muller EGD (1994) Deoxyribonucleotides are maintained at normal levels in a yeast thioredoxin mutant defective in DNA synthesis. J Biol Chem 269:24466-24471
51. Nakanishi N, Yamamoto M (1984) Analysis of the structure and transcription of the aro3 gene cluster in Schizosaccharomyces pombe. Mol Gen Genet 195:164-169
52. Nigro JM, Sikorski R, SI Reed SI, Vogelstein B (1992) Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol Cell Biol 12:1357-1365
53. Okamoto K, Beach D (1994) Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13:4816-4822
54. Okazaki K, Okazaki N, Kume S, Jinno S, Tanaka K, Okayama H (1990) High-frequency transformation method and library-transducing vectors for cloning mammalian cDNAs by transcomplementation in Schizosaccharomyces pombe. Nucleic Acids Res 18:6485
55. Okuno H, Akahori A, Sato H, Xanthoudakis S, Curran T, Iba H (1992) Escape from redox regulation enhances the transforming activity of fos. Oncogene 7:695-701
56. Raycroft L, Wu H, Lozano G (1990) Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051
57. Russel M, Model P, Holmgren A (1990) Thioredoxin or glutaredoxin in Escherichia coli is essential for sulfate reduction but not for deoxyribonucleotide synthesis. J Bacteriol 172: 1923-1929
58. Russell P (1989) Gene cloning and expression in fission yeast. In: Nasim A, Young P, Johnson BF (eds) Molecular biology of the fission yeast. Academic Press, New York, pp 244-271
59. Scharer E, Iggo R (1992) Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res 20:1539-1545
60. Shaulsky G, Ben-Ze'ev A, Rotter V (1990) Nuclear accumulation of p53 is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol 10:6567-6577
61. Soussi T, deFromental CC, May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952
62. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 altertion in human cancer: a review. Int J Cancer 57:1-9
63. II60. Science 267:100-104
64. Toledano MB, Kullik I, Trinh F, Baird PT, Schneider TD, Storz G (1994) Redox-dependent shift of OxyR-DNA contacts along an extended DNA binding site: a mechanism for different promoter selection. Cell 78:897-909
65. Truant R, Xiao H, Ingles CJ, Greenblatt J (1993) Direct interaction between the transactivation domain of human p53 and the TATA binding protein. J Biol Chem 268:2284-2287
66. Uemura T, Yanagidal M (1984) Isolation of type I and type II topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J 3:1737-1744
67. cdc2-reversible growth arrest in fission yeast. Oncogene 6:1539-1547
68. Wagner P, Grimaldi M, Jenkins JR (1993) Putative dehydrogenase tms1 suppresses growth arrest induced by a p53 tumor mutant in fission yeast. Eur J Biochem 217:731-736
69. Wu X, Bayle JH, Olson D, Levine AJ (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126-1132
70. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6 Nature 352:345-347
71. Zhang MQ, Marr TG (1994) Fission yeast gene structure and recognition. Nucleic Acids Res 22:1750-1759